Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Nanomedicine (Lond). 2013 Apr 23;8(11):1807–1813. doi: 10.2217/nnm.12.214

Figure 2. Patient interest by drug use.

Figure 2

Percentages of respondents who indicated that they definitely would, probably would, probably would not or definitely would not be interested in trying nanoformulated parenteral antiretroviral therapy by (A) drug use in the previous 6 months and by (B) intravenous drug use in the previous 6 months. The actual number of respondents to each specific question is included in parentheses.